Perfil
Joël Richard is currently a member of the Scientific & Medical Council at GlioCure SAS.
He previously worked as the Managing Director at OctreoPharm Sciences GmbH, Development Director at Ipsen Dreux, and Senior Vice President-Pharma Development at Ipsen SA. He is also currently serving as the Chief Scientific Officer at MedinCell SA, a position he has held since 2022 and will continue until 2023.
Cargos activos de Joël Richard
| Empresas | Cargo | Inicio |
|---|---|---|
GlioCure SAS
 GlioCure SAS BiotechnologyHealth Technology GlioCure SAS is a French biopharmaceutical company that focuses on discovering and developing new drugs to treat glioma and pediatric brain tumors. The private company is based in Angers, France. | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Joël Richard.
| Empresas | Cargo | Fin |
|---|---|---|
| MEDINCELL S.A. | Director Técnico/Científico/I+D | 01/02/2023 |
| IPSEN | Corporate Officer/Principal | - |
| Ipsen Dreux | Corporate Officer/Principal | - |
OctreoPharm Sciences GmbH
 OctreoPharm Sciences GmbH Pharmaceuticals: MajorHealth Technology OctreoPharm Sciences GmbH develops and manufactures pharmaceutical products. It operates as a clinical development biopharmaceutical company which focuses on radiopharmaceuticals for the diagnosis and therapeutic control of tumors. The company was founded by Hakim Larbi Bouterfa and Udo Blaseg in 2010 and is headquartered in Berlin, Germany. | Director Ejecutivo | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| IPSEN | Health Technology |
| MEDINCELL S.A. | Health Technology |
| Empresas privadas | 3 |
|---|---|
OctreoPharm Sciences GmbH
OctreoPharm Sciences GmbH Pharmaceuticals: MajorHealth Technology OctreoPharm Sciences GmbH develops and manufactures pharmaceutical products. It operates as a clinical development biopharmaceutical company which focuses on radiopharmaceuticals for the diagnosis and therapeutic control of tumors. The company was founded by Hakim Larbi Bouterfa and Udo Blaseg in 2010 and is headquartered in Berlin, Germany. | Health Technology |
GlioCure SAS
GlioCure SAS BiotechnologyHealth Technology GlioCure SAS is a French biopharmaceutical company that focuses on discovering and developing new drugs to treat glioma and pediatric brain tumors. The private company is based in Angers, France. | Health Technology |
| Ipsen Dreux |
- Bolsa de valores
- Insiders
- Joël Richard
